Contact
Please use this form to send email to PR contact of this press release:
Global Blood Therapeutics Announces New Details on its Novel Patient Reported Outcomes (PRO) Tool to be used in Phase 3 HOPE Study
TO:
Please use this form to send email to PR contact of this press release:
Global Blood Therapeutics Announces New Details on its Novel Patient Reported Outcomes (PRO) Tool to be used in Phase 3 HOPE Study
TO: